What?
How?
Client Value?
European Union Pharmaceutical Company
Following an initial TNFD assessment, the client requested a review of their existing biodiversity and sustainability work to support the co-development of an overarching Biodiversity Strategy. The engagement focused on defining a clear set of science-based biodiversity targets aligned with material environmental topics, ensuring coherence with ongoing sustainability initiatives, and identifying practical actions to advance nature-related commitments. The client’s TNFD report and sustainability strategy were reviewed, with practical recommendations provided to enhance the approach to biodiversity. Collaborative workshops with key internal stakeholders were facilitated to build consensus on ambition, targets, and actionable steps, ensuring alignment with broader sustainability workstreams. The outcomes were formalised into a draft Biodiversity Strategy, including clear, evidence-based actions and an executive summary to support senior leadership engagement. The client required a consistent, operational approach to track progress toward their nature commitments, support strategic decision-making, and meet regulatory and disclosure requirements (e.g., CSRD, EUDR). A Nature Impact Measurement Framework was co-designed covering ten internal targets across core workstreams – including water, land, and biodiversity – spanning both operations and supply chains. The framework applied the Pressure–State–Response and SBTN AR³T models to link actions to outcomes, focusing on pragmatic, decision-useful metrics addressing the client’s most material impacts. The work was delivered through an iterative, workshop-based process with client teams to define success, select aligned metrics, and develop a phased implementation roadmap consistent with leading global nature frameworks. This approach ensured the framework was tailored to the client’s strategic priorities and operational realities, supporting both decision-making and future reporting requirements.
The engagement provided the client with a clear, actionable roadmap to advance biodiversity initiatives, integrating science-based targets with internal priorities and material environmental topics. The highly collaborative, co-development approach supported consensus-building across internal stakeholders and clarified ambition and targets, while the expert review of existing strategies ensured biodiversity was coherently integrated within ongoing sustainability initiatives. The resulting Biodiversity Strategy positioned biodiversity as a strategic pillar within the broader sustainability agenda, with a clear set of targets agreed with senior leadership. The engagement delivered a fully defined Nature Impact Measurement Framework with clear metrics, target definitions, and a phased roadmap linking near-term actions to the client’s ambitions. By co-designing the framework through an iterative, workshop-based approach, the client gained a robust, evidence-based framework that translates strategy into actionable metrics while building internal understanding and ownership. The framework operationalises the client’s strategic approach to nature, strengthens readiness for compliance and reporting, embeds nature into enterprise risk management, and provides a robust evidence base to prioritise investments. By focusing on metrics that drive action rather than reporting alone, the framework offers a practical, actionable system to track progress credibly, enhance resilience, and support long-term value creation.
Supported the co-develop- ment of a global Biodiversi- ty Strategy.
Transition
Global Pharmaceutical Company
Supported the develop- ment of a Nature Impact Measurement Framework.
Transition
Integration
Contact the team For more information about our services
Lauren Weatherdon, MSc Business Director, Nature Services lauren.weatherdon @thebiodiversityconsultancy.com
Made with FlippingBook flipbook maker